Patrick Donnelly
Stock Analyst at Citigroup
(3.72)
# 785
Out of 5,033 analysts
341
Total ratings
53.8%
Success rate
6.13%
Average return
Main Sectors:
Stocks Rated by Patrick Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QDEL QuidelOrtho | Downgrades: Neutral | $40 → $33 | $29.02 | +13.71% | 6 | Oct 7, 2025 | |
| MTD Mettler-Toledo International | Maintains: Buy | $1,400 → $1,600 | $1,357.26 | +17.88% | 14 | Aug 21, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Neutral | $225 → $200 | $188.45 | +6.13% | 10 | Aug 21, 2025 | |
| TECH Bio-Techne | Upgrades: Buy | $55 → $70 | $62.54 | +11.93% | 12 | Aug 21, 2025 | |
| CAI Caris Life Sciences | Maintains: Buy | $34 → $42 | $31.50 | +33.33% | 2 | Aug 13, 2025 | |
| BRKR Bruker | Maintains: Neutral | $40 → $38 | $38.11 | -0.29% | 17 | Aug 4, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $150 → $200 | $184.14 | +8.61% | 21 | Jul 9, 2025 | |
| HOLX Hologic | Upgrades: Buy | $60 → $80 | $71.87 | +11.31% | 15 | Jul 9, 2025 | |
| ILMN Illumina | Downgrades: Sell | $85 → $80 | $99.50 | -19.60% | 17 | Jul 9, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Buy | $400 → $350 | $321.90 | +8.73% | 16 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $350 | $320.95 | +9.05% | 15 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $13.14 | +14.16% | 12 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $22 → $18 | $15.18 | +18.58% | 8 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $225 → $210 | $212.05 | -0.97% | 10 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $650 → $570 | $543.84 | +4.81% | 19 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $185 | $190.41 | -2.84% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $265 | $208.39 | +27.17% | 12 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $23 | $10.42 | +120.73% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $20 | $16.71 | +19.69% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $62.73 | +19.56% | 13 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $143.00 | +15.38% | 26 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $45 | $70.20 | -35.90% | 9 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $28 | $25.86 | +8.28% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $95.31 | +52.14% | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $62 | $48.67 | +26.98% | 13 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $265 → $300 | $343.18 | -12.58% | 24 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $3.04 | +196.05% | 6 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.75 → $2.75 | $3.37 | -18.40% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $250 → $260 | $290.93 | -10.63% | 11 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $10.12 | -40.71% | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $28 → $32 | $7.90 | +305.06% | 2 | Nov 30, 2018 |
QuidelOrtho
Oct 7, 2025
Downgrades: Neutral
Price Target: $40 → $33
Current: $29.02
Upside: +13.71%
Mettler-Toledo International
Aug 21, 2025
Maintains: Buy
Price Target: $1,400 → $1,600
Current: $1,357.26
Upside: +17.88%
ICON Public Limited Company
Aug 21, 2025
Downgrades: Neutral
Price Target: $225 → $200
Current: $188.45
Upside: +6.13%
Bio-Techne
Aug 21, 2025
Upgrades: Buy
Price Target: $55 → $70
Current: $62.54
Upside: +11.93%
Caris Life Sciences
Aug 13, 2025
Maintains: Buy
Price Target: $34 → $42
Current: $31.50
Upside: +33.33%
Bruker
Aug 4, 2025
Maintains: Neutral
Price Target: $40 → $38
Current: $38.11
Upside: -0.29%
Charles River Laboratories International
Jul 9, 2025
Upgrades: Buy
Price Target: $150 → $200
Current: $184.14
Upside: +8.61%
Hologic
Jul 9, 2025
Upgrades: Buy
Price Target: $60 → $80
Current: $71.87
Upside: +11.31%
Illumina
Jul 9, 2025
Downgrades: Sell
Price Target: $85 → $80
Current: $99.50
Upside: -19.60%
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $400 → $350
Current: $321.90
Upside: +8.73%
May 2, 2025
Maintains: Buy
Price Target: $400 → $350
Current: $320.95
Upside: +9.05%
Mar 4, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $13.14
Upside: +14.16%
Mar 4, 2025
Maintains: Neutral
Price Target: $22 → $18
Current: $15.18
Upside: +18.58%
Mar 4, 2025
Maintains: Neutral
Price Target: $225 → $210
Current: $212.05
Upside: -0.97%
Mar 4, 2025
Maintains: Neutral
Price Target: $650 → $570
Current: $543.84
Upside: +4.81%
Mar 4, 2025
Downgrades: Neutral
Price Target: $185
Current: $190.41
Upside: -2.84%
Jan 30, 2025
Maintains: Buy
Price Target: $285 → $265
Current: $208.39
Upside: +27.17%
Dec 11, 2024
Downgrades: Neutral
Price Target: $30 → $23
Current: $10.42
Upside: +120.73%
Nov 6, 2024
Maintains: Buy
Price Target: $18 → $20
Current: $16.71
Upside: +19.69%
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $62.73
Upside: +19.56%
Aug 22, 2024
Maintains: Buy
Price Target: $150 → $165
Current: $143.00
Upside: +15.38%
Aug 8, 2024
Maintains: Buy
Price Target: $40 → $45
Current: $70.20
Upside: -35.90%
Aug 7, 2024
Maintains: Buy
Price Target: $30 → $28
Current: $25.86
Upside: +8.28%
Jul 30, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $95.31
Upside: +52.14%
Feb 8, 2024
Maintains: Buy
Price Target: $64 → $62
Current: $48.67
Upside: +26.98%
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $343.18
Upside: -12.58%
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $3.04
Upside: +196.05%
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $3.37
Upside: -18.40%
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $290.93
Upside: -10.63%
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $10.12
Upside: -40.71%
Nov 30, 2018
Upgrades: Neutral
Price Target: $28 → $32
Current: $7.90
Upside: +305.06%